We narrowed to 5,873 results for: SPI;
-
Plasmid#111075PurposeFast anion channelrhodopsin (current half-decay time 3-10 ms depending on voltage and light intensity) for time-resolved inhibition of neuronal spikingDepositorInsertAnion channelrhodopsin RapACR
UseLentiviralTagsEYFPAvailable SinceJune 4, 2018AvailabilityAcademic Institutions and Nonprofits only -
pFUGW-RapACR_T111C-EYFP
Plasmid#119195PurposeFast anion channelrhodopsin mutant RapACR_T111C for time-resolved inhibition of neuronal spikingDepositorInsertAnion channelrhodopsin RapACR fast mutant T111C
UseLentiviralTagsEYFPMutationchanged threonine 111 to cysteinePromoterUbiquitinAvailable SinceDec. 7, 2018AvailabilityAcademic Institutions and Nonprofits only -
pRPL28(K55M) SpHIS5 (pNTI666)
Plasmid#115436PurposeExpresses K55M RPL28 from HIS3 yeast plasmidDepositorInsertsExpressionYeastMutationK55M; MfeI site in intronPromoterAshbya gospii TEF1 and endogenousAvailable SinceOct. 24, 2018AvailabilityAcademic Institutions and Nonprofits only -
pSFG-TFII-I-GFP beta
Plasmid#22200DepositorAvailable SinceNov. 13, 2009AvailabilityAcademic Institutions and Nonprofits only -
pSFG-TFII-I-GFP delta
Plasmid#22190DepositorAvailable SinceNov. 13, 2009AvailabilityAcademic Institutions and Nonprofits only -
pCMV-myc-ASPM CTR
Plasmid#27669DepositorInsertAbnormal spindle-like microcephaly associated (Aspm Rat)
TagsGFPExpressionMammalianMutationContains carboxy terminal region of ASPM (amino a…Available SinceMarch 21, 2011AvailabilityAcademic Institutions and Nonprofits only -
-
pBS U6 WIP RNAi
Plasmid#11774DepositorAvailable SinceFeb. 15, 2007AvailabilityAcademic Institutions and Nonprofits only -
pET24a-VHH-TagRFP657
Plasmid#243767PurposeBacterial expression of a functionalized anti-GFP (VHH) nanobody fused to TagRFP657. VHH-TagRFP657 also contains a T7, HA, BAP and His6 epitopeDepositorInsertanti-GFP nanobody VHH
TagsT7-TEV site and TagRFP657-HA-AviTag-6xHisExpressionBacterialPromoterT7Available SinceJan. 7, 2026AvailabilityAcademic Institutions and Nonprofits only -
pET24a-VHH-mNeptune2.5
Plasmid#243765PurposeBacterial expression of a functionalized anti-GFP (VHH) nanobody fused to mNeptune2.5. VHH-mNeptune2.5 also contains a T7, HA, BAP and His6 epitopeDepositorInsertanti-GFP nanobody VHH
TagsT7-TEV site and mNeptune2.5-HA-AviTag-6xHisExpressionBacterialPromoterT7Available SinceNov. 13, 2025AvailabilityAcademic Institutions and Nonprofits only -
pET24a-VHH-iRFP670
Plasmid#243768PurposeBacterial expression of a functionalized anti-GFP (VHH) nanobody fused to iRFP670. VHH-iRFP670 also contains a T7, HA, BAP and His6 epitopeDepositorInsertanti-GFP nanobody VHH
TagsT7-TEV site and iRFP670-HA-AviTag-6xHisExpressionBacterialPromoterT7Available SinceOct. 23, 2025AvailabilityAcademic Institutions and Nonprofits only -
185_pETcon_SARS2_BQ1-1
Plasmid#208085Purposeyeast surface display of the SARS-CoV-2 BQ.1.1 variant RBDDepositorAvailable SinceOct. 4, 2023AvailabilityAcademic Institutions and Nonprofits only -
LLP736_L2pV1_1I_Act2_FRT_OCS_TCTP_Flp_lacZ
Plasmid#192379PurposeTo test if the TCTP promoter can drive the Flp recomhinase in order to remove the OCS terminator and increase circuit output (despite the presence of the lacZ endlinker).DepositorInsertAct2::FRT-OCS-FRT::Rluc
UseSynthetic BiologyTagsPESTExpressionPlantAvailable SinceNov. 22, 2022AvailabilityAcademic Institutions and Nonprofits only -
pCMV-dLbCpf1-BE-EE
Plasmid#154147PurposeExpresses dLbCpf1-BE-EE(dLbCas12a-BE-EE) in mammalian cells.DepositorInsertdLbCpf1-BE-EE (dCas12a-BE-EE)
TagsSV40 NLSExpressionMammalianMutationAPOBEC1(R126E+R132E), dLbCpf1(D832A+E925A+D1148A)PromoterCMVAvailable SinceAug. 24, 2022AvailabilityAcademic Institutions and Nonprofits only -
pRPL28 SpHIS5 (pNTI663)
Plasmid#115433PurposeExpresses wild-type RPL28 from HIS3 yeast plasmidDepositorInsertsExpressionYeastMutationMfeI site in intronPromoterAshbya gospii TEF1 and endogenousAvailable SinceOct. 24, 2018AvailabilityAcademic Institutions and Nonprofits only -
pRPL28(Q38P) SpHIS5 (pNTI664)
Plasmid#115434PurposeExpresses Q38P RPL28 from HIS3 yeast plasmidDepositorInsertsExpressionYeastMutationQ38P; MfeI site in intronPromoterAshbya gospii TEF1 and endogenousAvailable SinceOct. 24, 2018AvailabilityAcademic Institutions and Nonprofits only -
pRPL28(H39L) SpHIS5 (pNTI665)
Plasmid#115435PurposeExpresses H39L RPL28 from HIS3 yeast plasmidDepositorInsertsExpressionYeastMutationH39L; MfeI site in intronPromoterashbya gospii TEF1 and endogenousAvailable SinceOct. 24, 2018AvailabilityAcademic Institutions and Nonprofits only -
pEBG-TFII-I L30&37P
Plasmid#22166DepositorInsertTFII-I (GTF2I Human)
TagsGST and HisExpressionMammalianMutationChanged Leucine 30 to Proline and changed leucine…Available SinceNov. 13, 2009AvailabilityAcademic Institutions and Nonprofits only -
AiP14035: pAAV-AiE0452h_3xC2-minBG-CoChR-EGFP-WPRE3-BGHpA (Alias: CN4035) (AAV PHP.eB)
Viral Prep#214853-PHPeBPurposeReady-to-use AAV PHP.eB particles produced from AiP14035: pAAV-AiE0452h_3xC2-minBG-CoChR-EGFP-WPRE3-BGHpA (Alias: CN4035) (#214853). In addition to the viral particles, you will also receive purified AiP14035: pAAV-AiE0452h_3xC2-minBG-CoChR-EGFP-WPRE3-BGHpA (Alias: CN4035) plasmid DNA. minBG-driven expression of CoChR-EGFP striatal indirect pathway medium spiny neurons (D2 MSNs). These AAV were produced with the PHPeB serotype, which permits efficient transduction of the central nervous system. These AAV preparations are suitable purity for injection into animals.DepositorTagsEGFPAvailable SinceNov. 13, 2024AvailabilityAcademic Institutions and Nonprofits only -
AiP14033: pAAV-AiE0779m_3xC2-minBG-CoChR-EGFP-WPRE3-BGHpA (Alias: CN4033) (AAV PHP.eB)
Viral Prep#214852-PHPeBPurposeReady-to-use AAV PHP.eB particles produced from AiP14033: pAAV-AiE0779m_3xC2-minBG-CoChR-EGFP-WPRE3-BGHpA (Alias: CN4033) (#214852). In addition to the viral particles, you will also receive purified AiP14033: pAAV-AiE0779m_3xC2-minBG-CoChR-EGFP-WPRE3-BGHpA (Alias: CN4033) plasmid DNA. minBG-driven expression of CoChR-EGFP in striatal direct pathway medium spiny neurons (D1 MSNs). These AAV were produced with the PHPeB serotype, which permits efficient transduction of the central nervous system. These AAV preparations are suitable purity for injection into animals.DepositorTagsEGFPAvailable SinceNov. 13, 2024AvailabilityAcademic Institutions and Nonprofits only